Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06858618 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a Phase 2, open-label, multicenter study to safety \& tolerability, antitumor activity, and pharmacokinetics of FCN-338 in Combination with szacitidine (AZA) or chemotherapy(erythromycin, cytarabine(Ara-C)) in Patients with myeloid neoplasms
Trial Details
NCT Number NCT06858618
Lead Sponsor Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Collaborators: Beijing Fosun Pharmaceutical Technology Development Co., Ltd.
Conditions
(from sponsor)		 Safety, Antitumor Activity, PK Profile
Related terms Leukemia, Myeloid, Acute
Enrollment 47 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov